ClinConnect ClinConnect Logo
Search / Trial NCT05364372

SMLI With Hispanic Cancer Survivors and Caregivers

Launched by UNIVERSITY OF ARIZONA · May 5, 2022

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Cancer Survivors Caregivers Symptom Assessment Lifestyle Intervention Diet Physical Activity

ClinConnect Summary

This clinical trial is looking at ways to help Hispanic cancer survivors and their caregivers improve their health and well-being. Many Hispanic cancer survivors struggle with symptoms like pain, anxiety, and fatigue even after treatment, and less than 20% follow the recommended guidelines for nutrition and physical activity. The study will test a program designed to help these survivors adopt healthier lifestyle habits, which can reduce symptoms and lower the risk of cancer returning.

To participate, survivors must be at least 18 years old, have completed their cancer treatment within the last 10 years, and have at least one significant symptom. They also need to have a caregiver who can join them in the study. Caregivers must be 18 or older and not currently receiving cancer treatment themselves. Participants can expect to engage in activities that promote better nutrition and physical activity, which could lead to improved health outcomes. This trial is a great opportunity for eligible individuals to receive support and potentially enhance their quality of life after cancer treatment.

Gender

ALL

Eligibility criteria

  • Inclusion criteria for female Hispanic cancer survivors:
  • 1. 18 years of age or older;
  • 2. have access to a telephone,
  • 3. speak and understand English or Spanish;
  • 4. have finished curative intent treatment for cancer within the previous 10 years and do not have any subsequent cancer treatments planned, except for non-curative intent maintenance therapy, such as hormonal therapy;
  • 5. must have at least 1 of the 5 most common cancer-related symptoms (pain, sleep disturbance, anxiety, depression and/or fatigue) with a severity score of 4 or higher on a 0-10 rating scale (based on NCCN guidelines for symptom monitoring and management used successfully in past work); and
  • 6. has a caregiver willing to participate in the study with them.
  • Inclusion criteria for the caregivers (nominated by the survivor) are:
  • 1. age 18 or older;
  • 2. able to speak and understand English or Spanish;
  • 3. access to a telephone; and
  • 4. not currently treated for cancer preserving the distinction between survivor and caregiver. The caregiver can be of any race or ethnicity and any gender.
  • Exclusion criteria for survivors:
  • 1. Under the age of 18 years
  • 2. Does not have access to a telephone
  • 3. Completed treatment for cancer more than 1 year ago
  • 4. Currently receiving counseling or treatment for special diet or weight loss
  • 5. Does not have a caregiver willing to participate with them
  • Exclusion criteria for caregivers:
  • 1. Under the age of 18 years
  • 2. Does not have access to a telephone
  • 3. Currently receiving counseling or treatment for special diet or weight loss
  • 4. Currently being treated for cancer

About University Of Arizona

The University of Arizona is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore new therapeutic approaches and enhance patient outcomes. Committed to ethical research practices and community engagement, the University of Arizona fosters an environment that promotes scientific discovery and the translation of research findings into clinical applications. Its clinical trial initiatives encompass a wide range of medical disciplines, reflecting the institution's mission to improve health and well-being locally and globally.

Locations

Tucson, Arizona, United States

Patients applied

0 patients applied

Trial Officials

Jennifer Bea, PhD

Principal Investigator

University of Arizona

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials